Manufacturer
SpecGx LLC
25 drugs, 115 product strengths, 2 recalls on record.
Drugs SpecGx LLC makes
Methylphenidate-1.0%Generic · 28 makersPharmacies pay from$3.65Unavailable1 open recallDextroamphetamine+2.4%Generic · 11 makersPharmacies pay from$11.47Amphetamine+0.6%Generic · 10 makersPharmacies pay from$13.55In shortageOxycodone+4.5%Generic · 28 makersPharmacies pay from$2.772 open recallsBuprenorphine+0.6%Generic · 26 makersPharmacies pay from$8.626 open recallsNaltrexone-1.3%Generic · 22 makersPharmacies pay from$33.69Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate-2.4%Generic · 25 makersPharmacies pay from$6.81Unavailable6 open recallsLisdexamfetamine+6.8%Generic · 18 makersPharmacies pay from$74.56Limited availability8 open recallsAcetaminophen / hydrocodone-3.1%Generic · 31 makersPharmacies pay from$3.92Posaconazole+1.7%Generic · 28 makersPharmacies pay from$62.01Being discontinued1 open recallBuprenorphine / naloxone+8.2%Generic · 22 makersPharmacies pay from$16.17Acetaminophen / oxycodone-0.4%Generic · 23 makersPharmacies pay from$3.532 open recallsMorphine+0.1%Generic · 17 makersPharmacies pay from$6.32Unavailable7 open recallsAcetaminophen / codeine-3.4%Generic · 22 makersPharmacies pay from$7.41Atropine / diphenoxylate+2.9%Generic · 20 makersPharmacies pay from$4.28Hydromorphone+0.5%Generic · 15 makersPharmacies pay from$5.12Unavailable3 open recallsTemazepam-1.5%Generic · 18 makersPharmacies pay from$2.19Methadone+2.7%Generic · 16 makersPharmacies pay from$4.951 open recallClomipramine+7.6%Generic · 13 makersPharmacies pay from$6.093 open recallsFentanyl-0.4%Generic · 9 makersPharmacies pay from$87.97Unavailable22 open recallsPrucalopride-0.9%Generic · 12 makersPharmacies pay from$18.46Levorphanol+70.3%Generic · 7 makersPharmacies pay from$5442 open recallsAmitizaNo changeBrand · lubiprostonePharmacies pay from$193PercocetNo changeBrand · acetaminophen / oxycodonePharmacies pay from$879Roxicodone-0.1%Brand · oxycodonePharmacies pay from$164
Recalls
Class IIOngoingJan 14, 2026Oxycodone and Acetaminophen CII Tablets USPFailed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.SpecGx, LLC · D-0254-2026Class IIOngoingJan 14, 2026Oxycodone and Acetaminophen CII Tablets USPFailed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.SpecGx, LLC · D-0255-2026
About SpecGx LLC
No comments yet. Questions, tips, what worked for you - start the conversation.